The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

by Anna Azvolinsky

Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.

by Anna Azvolinsky

Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

by Melvin Mann

Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

by Ashley P. Taylor

Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.

by Marci A. Landsmann

Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.

by Jon Kelvey

Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.

by Emma Yasinski

People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

by Jon Kelvey

A clinical trial comparing acupuncture and cognitive behavioral therapy found that they are both helpful for people who are experiencing sleep problems after cancer treatment.

by Cheryl Platzman Weinstock

Cancer patient advocates who review research proposals can provide valuable perspective.

by Bob Riter, Monica Vakiner and Carole Baas